
SOTS 2nd Hour: The Disney Breakdown: Plus CFO Hugh Johnston, Pharma Risks Loom, and Taylor Morrison CEO 5/7/25
Squawk on the Street
00:00
Pharmaceutical Industry Under Pressure and Disney's Earnings Surge
This chapter discusses recent changes in the pharmaceutical landscape, especially the appointment of a new FDA chief for vaccines and its repercussions for drug manufacturers. It also explores issues related to Medicaid pricing policies and includes highlights from international news and earnings, featuring Disney's recent success.
Transcript
Play full episode